||Conference on Medical Screening and Biological Monitoring for the Effects of Exposure in the Workplace, July 1984. Part 2.
||National Inst. for Occupational Safety and Health, Cincinnati, OH.;National Cancer Inst., Bethesda, MD.;Environmental Protection Agency, Washington, DC.
Industrial medicine ;
Work environments ;
Socioeconomic factors ;
Legal problems ;
Biological monitoring ;
Diagnostic services ;
Medical procedures ;
Occupational Safety and Health
||Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy.
||The papers presented reflected problems associated with medical screening and biomonitoring for the effects of occupational exposure. There were three primary topics considered at the conference. The first dealt with the legal, social and ethical issues related to medical screening and medical monitoring. The second topic concerned issues in assessment and evaluation of screening programs. The exercise tolerance test as a screening test in coronary heart disease, use of chest radiography for low back pain screening, screening for bladder cancer, diagnostic techniques for use in certain diseases dermatologic screening, damage from exposure to benzo(a)pyrene (50328), computerized screening for neurobehavioral changes in the workplace, detection of early pregnancy and fetal loss, and respiratory function tests in the screening of workers were emphasized. Occupational ecogenetics, interactions between genes and environment in the workplace, epidemiological use of genetic screening in the workplace, chromosome alterations as markers of exposure and effect, and immunoassays to adducts of benzo(a)pyrene and DNA in the biomonitoring of workers exposed to carcinogens, comprised the third major topic of the conference. (Copyright (c) 1986 by the American Occupational Medical Association.)
||Also pub. as Jnl. of Occupational Medicine, v28 n10 Oct 86. See also Part 1, PB87-155420. Color illustrations reproduced in black and white. Sponsored by National Cancer Inst., Bethesda, MD., and Environmental Protection Agency, Washington, DC.
||Reprint: Conference on Medical Screening and Biological Monitoring for the Effects of Exposure in the Workplace, July 1984. Part 2.
|PUB Date Free Form
||57U; 41; 95C; 68G
||PC A12/MF A01